Welcome to the EAASM website  

Contact us at enquiries@eaasm.eu to share your experiences of buying medicines online, or receiving medicines from your pharmacist which have seemed out of the ordinary.

The European Alliance for Access to Safe Medicines (EAASM) is an independent, pan-European initiative dedicated to protecting patient safety by ensuring access to safe and legitimate medicines. The Alliance was formed by a cross-section of European stake-holders from a variety of backgrounds. Its key activities include campaigning for the safer use of unlicensed or off-label medicines and also the exclusion of counterfeit and substandard medicines from the supply chain, raising public awareness around such issues, and promoting effective legislation and enforcement in relation to falsified medicines. For a leaflet summarising the EAASM's activities and achievements click here

On this website you will find a wealth of information about counterfeit and substandard medicines. Our top tips section will help you to reassure yourself that the prescription medicine you are buying is genuine. Our news section will provide you with the latest news on counterfeit medicines in Europe and around the world as well as updates about the EAASM activities. The EAASM constantly updates and adds useful resources to the website so you can get as much information as possible about obtaining safe medicines.

Latest News

ASOP EU member adopts top level domain name .pharmacy

23 Mar 2017

To help ensure absolute security and recognition of a genuine fully legal online seller of medicines, the web page of the European Association of Mail Service Pharmacies (EAMSP) recently became the first in Europe to switch its Top Level Domain to .pharmacy. 

EAASM and ASOP EU to be present at the 22nd Congress of the European Association Of Hospital Pharmacists 22-24 March 2017

10 Mar 2017

Mike Isles will be speaking on “Falsified Medicines: The Role of the Pharmacist in Raising Patient Awareness.

Study on off-label use of medicinal products in the European Union now published

28 Feb 2017

Commissioned in 2014 to understand the ramification of the issue, the study sheds light on the drivers behind the increasing use of off-label medicines in Europe, as well as the opportunities and challenges linked to it.